FDA Drugs recall ·

Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only… recall

Recall number
D-0403-2026
Date
(initiated February 26, 2026)
Company / brand
Macleods Pharma USA, Inc
103 College Rd E Fl 2, Princeton, NJ, United States
Category
Drugs › Class II
Classification
Class II
Status
Ongoing
Units affected
1315 bottles
Hazard tags
Potency
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Guajarat, INDIA NDC 33342-401-44

Why was it recalled?

Subpotent Drug

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Lot 16240062A, exp date 3/2026

Distribution

Nationwide

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (drugs), recall D-0403-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.